Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications how zoonotic disease surveillance can influence evidence based policy decisions one
… New Real-World Evidence of Effective Treatment in Non-Small-Cell Lung Cancer … 2023 Non-small cell lung cancer (NSCLC) is an aggressive disease, with poor prognosis and a high likelihood of brain … duration of response, time-to-treatment discontinuation, disease control rate, and progression-free survival in a …
… across therapeutic areas . Our integrated team approach can help you achieve the best result for your product. We can support you in any aspects of research and product …
… that the agencies use different standards to evaluate evidence from patient-reported outcomes (PROs) in clinical … PRO drug labeling who understand these differences can use that knowledge to guide their PRO measurement … PRO-related endpoints in cancer clinical research? And how can these challenges be overcome? • What are the emerging …
… of autoimmune disorders. Our experience includes: Celiac disease Immunoglobulin treatments Lupus erythematosus … budget Impact) Drug utilization studies Epidemiology of disease Measurement of patient preferences for treatment …
… clinical trials, and there are other factors as well. How is the pharmaceutical industry responding to these new … more large-molecule drugs or biologicals instead. On the disease-area level, companies might be thinking of … client’s own teams to merge their expertise with ours. We can help develop IRA and EU HTA regulation impact analyses, …
… Real-World Evidence Videos Learn more about our expertise in real-world evidence research with these videos from our researchers. …
… September 27, 2018, 10 - 11am Watch the Recording Going One Step Further in Observational Studies: Design Strategies … efficiency in observational studies . You’ll learn How to map the identifiability conditions of causal effects … in an observational study To identify the problems that can arise when eligibility, start of follow-up, and exposure …
… our presentation. If you would like to speak with us about how we can help you with your specific Global Value Dossier needs, … all safety data and a thorough review of the clinical evidence. However, the value messages will focus on the …
… our clients on projects to research rare diseases, rare disease treatment, and complications and comorbidities of … alveolar proteinosis Autosomal dominant polycystic kidney disease Central precocious puberty disease Cushing's disease Cystic fibrosis Duchenne muscular …
… study in which a product or new use is being investigated, how it relates to the overall product development plan, … from Phase 1, Phase 2, and Phase 3 studies (peer-reviewed publications; congress abstracts, posters, and presentations; … data on file – at the discretion of the manufacturer Disease information Product information Version 4.1 (2020) …